| 引用本文: |
施利,毛丹,张绍钒,黄建华,刘新义,张英进,雷三林,马进安,向大雄,胡春宏,张四方.健脾解毒方对大肠癌细胞mTOR信号通路相关蛋白表达的影响[J].湖南中医药大学学报,2016,36(12):11-16[点击复制] |
|
| |
|
|
| 本文已被：浏览 2693次 下载 1522次 |
| 健脾解毒方对大肠癌细胞mTOR信号通路相关蛋白表达的影响 |
| 施利,毛丹,张绍钒,黄建华,刘新义,张英进,雷三林,马进安,向大雄,胡春宏,张四方 |
| (中南大学湘雅二医院, 湖南 长沙 410008;湖南中医药大学药学院, 湖南 长沙 410028) |
| 摘要: |
| 目的 探讨健脾解毒方对大肠癌细胞增殖的影响及可能作用机制。方法 采用水提法制作健脾解毒方提取物，利用超高效液相-高分辨飞行时间质谱法分析健脾解毒方的主要成分，MTT法检测健脾解毒方对大肠癌细胞增殖的影响，Graphpad Prism5软件计算IC50值，流式细胞术检测细胞周期，Western Blot技术检测Phospho-mTOR、Phospho-P53和P21的蛋白表达。结果 健脾解毒方能够抑制大肠癌细胞增殖，处理24、48、72 h后四种大肠癌细胞系的IC50值分别为HCT116（6.894、5.668、3.648 mg/mL）、LoVo（14.65、8.737、7.849 mg/mL）、SW48（8.029、7.026、5.740 mg/mL）及HT29（13.06、9.646、8.448 mg/mL）；健脾解毒方使大肠癌细胞周期阻滞在G1期；并能够下调Phospho-mTOR蛋白表达（P<0.05），上调Phospho-P53和P21蛋白的表达（P<0.05），使大肠癌细胞周期阻滞在G1期。结论 健脾解毒方可能通过mTOR-P53-P21途径抑制大肠癌细胞的增殖，这可能是健脾解毒方治疗大肠癌的作用机制之一。 |
| 关键词: 健脾解毒方 大肠癌 细胞增殖 半抑制浓度 mTOR |
| DOI：10.3969/j.issn.1674-070X.2016.12.003 |
| 投稿时间：2016-09-01 |
| 基金项目:国家自然科学基金面上项目（81273722）。 |
|
| Effect of Jianpi Jiedu Formula on the Expressions of Proteins Related to mTOR Signal Pathway in Colon Cancer Cell Line |
| SHI Li,MAO Dan,ZHANG Shaofan,HUANG Jianhua,LIU Xinyi,ZHANG Yinjin,LEI Sanlin,MA Jin'an,XIANG Daxiong,HU Chunhong,ZHANG Sifang |
| (The Second Hospital of Xiangya, Central South University, Changsha, Hunan 410011, China;School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan 410028, China) |
| Abstract: |
| Objective To investigate the effects of Jianpi Jiedu Formula (JPJD) on inhibiting colon cancer cell proliferation capacity and its possible mechanism. Methods The main components of water extract of JPJD were analyzed by UPLC-Q-TOF/MS. The effect of JPJD on colon cancer cell proliferation capacity was determined by MTT assays. The IC50 value concentration were calculated by Graphpad Prism5 software. The cell cycle was detected by Flow cytometric method. The protein levels of Phospho-mTOR (P-mTOR), Phospho-P53 (PP53) and P21 were examined by Western Blot. Results MTT assays demonstrated that JPJD can inhibite the colon cancer cell proliferation capacity. The IC50 value concentration of JPJD at 24 h, 48 h and 72 h after treatment were 6.894, 5.668, 3.648 mg/mL in HCT116 cell, 14.650, 8.737, 7.849 mg/mL in LoVo cell, 8.029, 7.029, 5.740 mg/mL in SW48 cell and 13.06, 9.646, 8.448 mg/mL in HT29 cell, respectively. JPJD could down-regulate the expression of Phospho-mTOR protein, up-regulate the expression of Phospho-P53 and P21 protein, and keep the cycle of the large intestine cancer cells at G1 phase. Conclusion The JPJD could inhibit HCT116, LoVo, SW48 and HT29 cells proliferation capacity by mTOR-P53-P21 signaling pathways, and it may be the probable mechanism of JPJD on colorectal cancer. |
| Key words: Jianpi Jiedu Formula colon cancer cell proliferation IC50 mTOR |
|
二维码（扫一下试试看！） |
|
|
|
|
